Drugs Similar to POTASSIUM CITRATE
POTASSIUM CITRATE
Related medications based on brand, generic name, substance, active ingredients.
By Brand
Drugs with the same brand name or brand family
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure
Potassium citrate USP (tripotassium citrate monohydrate) is a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets USP are pale yellow colored, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, and 10 mEq (1080 mg) potassium citrate each. Inactive ingredients include carnauba wax, magnesium stearate and stearic acid. Meets USP Dissolution Test 2. potassium-citrate-struct.jpg
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate extended-release tablets, USP are a citrate salt of potassium. It has the following chemical structure: K 3 C 6 H 5 O 7 • H 2 O M.W. 324.41 Potassium Citrate extended-release tablets, USP are tan to yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, USP, 10 mEq (1080 mg) potassium citrate, USP, and 15 mEq (1620 mg) potassium citrate, USP each. Inactive ingredients include carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure.
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium Citrate is a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 0 7 • H 2 0, and it has the following chemical structure: Potassium Citrate yellowish to tan, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Structure of Potassium Citrate
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate extended-release tablets, USP are a citrate salt of potassium. It has the following chemical structure: K 3 C 6 H 5 O 7 • H 2 O M.W. 324.41 Potassium Citrate extended-release tablets, USP are tan to yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, USP, 10 mEq (1080 mg) potassium citrate, USP, and 15 mEq (1620 mg) potassium citrate, USP each. Inactive ingredients include carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 . structure1
By Generic Name
Drugs with the same generic name (different brands)
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure
Potassium Citrate is a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 0 7 • H 2 0, and it has the following chemical structure: Potassium Citrate yellowish to tan, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Structure of Potassium Citrate
Potassium citrate USP (tripotassium citrate monohydrate) is a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets USP are pale yellow colored, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, and 10 mEq (1080 mg) potassium citrate each. Inactive ingredients include carnauba wax, magnesium stearate and stearic acid. Meets USP Dissolution Test 2. potassium-citrate-struct.jpg
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 Potassium citrate
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium Citrate extended-release tablets, USP are a citrate salt of potassium. It has the following chemical structure: K 3 C 6 H 5 O 7 • H 2 O M.W. 324.41 Potassium Citrate extended-release tablets, USP are tan to yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, USP, 10 mEq (1080 mg) potassium citrate, USP, and 15 mEq (1620 mg) potassium citrate, USP each. Inactive ingredients include carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate extended-release tablets, USP are a citrate salt of potassium. It has the following chemical structure: K 3 C 6 H 5 O 7 • H 2 O M.W. 324.41 Potassium Citrate extended-release tablets, USP are tan to yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, USP, 10 mEq (1080 mg) potassium citrate, USP, and 15 mEq (1620 mg) potassium citrate, USP each. Inactive ingredients include carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 . structure1
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
By Substance
Drugs sharing the same substance name
Summary not available yet.
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 Potassium citrate
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure.
Potassium Citrate extended-release tablets, USP are a citrate salt of potassium. It has the following chemical structure: K 3 C 6 H 5 O 7 • H 2 O M.W. 324.41 Potassium Citrate extended-release tablets, USP are tan to yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, USP, 10 mEq (1080 mg) potassium citrate, USP, and 15 mEq (1620 mg) potassium citrate, USP each. Inactive ingredients include carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP. structure
Potassium citrate USP (tripotassium citrate monohydrate) is a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets USP are pale yellow colored, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, and 10 mEq (1080 mg) potassium citrate each. Inactive ingredients include carnauba wax, magnesium stearate and stearic acid. Meets USP Dissolution Test 2. potassium-citrate-struct.jpg
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate extended-release tablets are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate extended-release tablets are off white to tan yellowish, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax, silicon dioxide and magnesium stearate. FDA approved dissolution test specifications differ from USP.
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 .
Potassium citrate is a citrate salt of potassium. Its molecular formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium citrate, USP is a transparent crystals or white, granular powder. It is freely soluble in water and slightly soluble in alcohol. Potassium citrate extended-release tablets, USP intended for oral administration, each contains 5 mEq (540 mg), 10 mEq (1,080 mg) or 15 mEq (1,620 mg) of potassium citrate, USP as monohydrate. In addition, each tablet contains the following inactive ingredients: carnauba wax and magnesium stearate. Meets USP Dissolution Test 2 figure
Potassium Citrate Extended-Release Tablets USP are a citrate salt of potassium. Its empirical formula is K 3 C 6 H 5 O 7 • H 2 O, and it has the following chemical structure: Potassium Citrate Extended-Release Tablets USP are off-white to yellow, oral wax-matrix tablets, contain 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate. Potassium Citrate Extended-Release Tablets USP meet USP Dissolution Test 4 . structure